NexturnBioscience Co. Ltd (089140) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.51 Billion ≈ $3.06 Million USD) by net assets (₩240.26 Billion ≈ $162.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of NexturnBioscience Co. Ltd to measure how many days the company can operate on defensive assets alone.

NexturnBioscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how NexturnBioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NexturnBioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NexturnBioscience Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Passat Société Anonyme PA:PSAT	0.017x
Veea Inc. NASDAQ:VEEA	-1.034x
Korean Air Lines Co Ltd KO:003495	0.185x
3R Games SA WAR:3RG	0.036x
FACILITIES BY ADF LS-01 F:ZC8	N/A
Reading International B Inc NASDAQ:RDIB	-0.285x
Xilam Animation PA:XIL	0.207x
Mighty Kingdom Ltd AU:MKL	-0.727x

Annual Cash Flow Conversion Efficiency for NexturnBioscience Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of NexturnBioscience Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see NexturnBioscience Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩136.62 Billion ≈ $92.59 Million	₩-1.14 Billion ≈ $-774.60K	-0.008x	+41.40%
2023-12-31	₩138.01 Billion ≈ $93.53 Million	₩-1.97 Billion ≈ $-1.34 Million	-0.014x	-29.82%
2022-12-31	₩108.27 Billion ≈ $73.38 Million	₩-1.19 Billion ≈ $-806.98K	-0.011x	-127.83%
2021-12-31	₩92.73 Billion ≈ $62.85 Million	₩3.66 Billion ≈ $2.48 Million	0.040x	+1520.67%
2020-12-31	₩96.77 Billion ≈ $65.58 Million	₩235.94 Million ≈ $159.89K	0.002x	-91.07%
2019-12-31	₩100.16 Billion ≈ $67.88 Million	₩2.74 Billion ≈ $1.85 Million	0.027x	-72.91%
2018-12-31	₩95.51 Billion ≈ $64.73 Million	₩9.63 Billion ≈ $6.52 Million	0.101x	+81.94%
2017-12-31	₩91.77 Billion ≈ $62.19 Million	₩5.08 Billion ≈ $3.45 Million	0.055x	-72.15%
2016-12-31	₩89.89 Billion ≈ $60.92 Million	₩17.88 Billion ≈ $12.12 Million	0.199x	+211.78%
2015-12-31	₩30.04 Billion ≈ $20.36 Million	₩1.92 Billion ≈ $1.30 Million	0.064x	-71.37%
2014-12-31	₩29.08 Billion ≈ $19.70 Million	₩6.48 Billion ≈ $4.39 Million	0.223x	--

About NexturnBioscience Co. Ltd

KQ:089140 Korea Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$17.14 Million

₩25.30 Billion KRW

Market Cap Rank

#25634 Global

#1871 in Korea

Share Price

₩2425.00

Change (1 day)

+0.83%

52-Week Range

₩2005.00 - ₩3065.00

All Time High

₩56500.00